Quest Diagnostics aligns with Allscripts for eprescribing initiative

Quest Diagnostics, a provider of diagnostic testing and information services, will collaborate with Allscripts, a provider of clinical software and information services, for the National ePrescribing Patient Safety Initiative (NEPSI). NEPSI is a joint project for the resolution of preventable medication errors.

The Lindhurst, N.J.-based Quest Diagnostics will provide free electronic laboratory orders and results for physicians who use Allscripts’ free, web-based NEPSI electronic prescribing application, eRx Now. The access will be available later this year.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.